ATE431144T1 - Neue formulierungen und ihre verwendung - Google Patents

Neue formulierungen und ihre verwendung

Info

Publication number
ATE431144T1
ATE431144T1 AT02799531T AT02799531T ATE431144T1 AT E431144 T1 ATE431144 T1 AT E431144T1 AT 02799531 T AT02799531 T AT 02799531T AT 02799531 T AT02799531 T AT 02799531T AT E431144 T1 ATE431144 T1 AT E431144T1
Authority
AT
Austria
Prior art keywords
new formulations
formulations
new
Prior art date
Application number
AT02799531T
Other languages
English (en)
Inventor
Tomas Landh
Nils-Olof Lindberg
Original Assignee
Mcneil Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ab filed Critical Mcneil Ab
Application granted granted Critical
Publication of ATE431144T1 publication Critical patent/ATE431144T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A23G1/42—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G1/426—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Psychology (AREA)
  • Food Science & Technology (AREA)
  • Obesity (AREA)
  • Microbiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT02799531T 2001-09-27 2002-09-10 Neue formulierungen und ihre verwendung ATE431144T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0103210A SE0103210D0 (sv) 2001-09-27 2001-09-27 New formulations and use thereof
PCT/SE2002/001612 WO2003026656A1 (en) 2001-09-27 2002-09-10 New formulations and use thereof

Publications (1)

Publication Number Publication Date
ATE431144T1 true ATE431144T1 (de) 2009-05-15

Family

ID=20285456

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02799531T ATE431144T1 (de) 2001-09-27 2002-09-10 Neue formulierungen und ihre verwendung

Country Status (19)

Country Link
EP (1) EP1429770B1 (de)
JP (1) JP4262094B2 (de)
KR (1) KR20040047868A (de)
CN (1) CN1561213A (de)
AR (1) AR036679A1 (de)
AT (1) ATE431144T1 (de)
AU (1) AU2002334523B2 (de)
BR (1) BR0212834A (de)
CA (1) CA2461757C (de)
DE (1) DE60232344D1 (de)
DK (1) DK1429770T3 (de)
ES (1) ES2325684T3 (de)
IL (1) IL160886A0 (de)
MX (1) MXPA04002876A (de)
NZ (1) NZ532528A (de)
RU (1) RU2282447C2 (de)
SE (1) SE0103210D0 (de)
WO (1) WO2003026656A1 (de)
ZA (1) ZA200402091B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767698B2 (en) 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
CN102669810B (zh) 2003-11-07 2014-11-05 美国无烟烟草有限责任公司 烟草组合物
CZ200980A3 (cs) * 2009-02-11 2010-04-28 Heglund A.S. Kompozice urcená k bukální absorpci nikotinu za úcelem odvykání kourení
RU2453754C1 (ru) * 2010-12-27 2012-06-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования Сибирский федеральный университет (СФУ) Устройство для бестраншейной замены трубопроводов
RU2448573C1 (ru) * 2010-12-27 2012-04-27 Олег Иванович Квасенков Способ получения некурительного изделия из махорки

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8404808L (sv) * 1983-10-03 1985-04-04 Avner Rotman Mikrokapslat lekemedel i sot matris
US5549906A (en) * 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
SE9803986D0 (sv) * 1998-11-23 1998-11-23 Pharmacia & Upjohn Ab New compositions
SE0103211D0 (sv) * 2001-09-27 2001-09-27 Pharmacia Ab New formulations and use thereof

Also Published As

Publication number Publication date
DE60232344D1 (de) 2009-06-25
AR036679A1 (es) 2004-09-29
ES2325684T3 (es) 2009-09-14
CA2461757A1 (en) 2003-04-03
CN1561213A (zh) 2005-01-05
JP4262094B2 (ja) 2009-05-13
MXPA04002876A (es) 2005-06-20
EP1429770A1 (de) 2004-06-23
NZ532528A (en) 2005-10-28
RU2004108853A (ru) 2005-04-20
DK1429770T3 (da) 2009-08-03
ZA200402091B (en) 2005-06-29
WO2003026656A1 (en) 2003-04-03
CA2461757C (en) 2008-09-02
AU2002334523B2 (en) 2007-02-15
BR0212834A (pt) 2004-10-13
RU2282447C2 (ru) 2006-08-27
EP1429770B1 (de) 2009-05-13
KR20040047868A (ko) 2004-06-05
JP2005503429A (ja) 2005-02-03
IL160886A0 (en) 2004-08-31
SE0103210D0 (sv) 2001-09-27

Similar Documents

Publication Publication Date Title
DE60230883D1 (de) Neue formulierungen und ihre verwendung
ATE533508T1 (de) Cripto-blockierende antikörper und ihre verwendung
ATE424202T1 (de) Substituierte 2-thio-3,5-dicyano-4-phenyl-6- aminopyridine und ihre verwendung
DE50115561D1 (de) Spektralphotometer und Verwendung desselben
DE50207849D1 (de) Substituierte 2-oxy-3,5-dicyano-4-aryl-6-aminopyridine und ihre verwendung
DE60106423D1 (de) Entzündungshemmende verbindungen und ihre verwendung
ATE406419T1 (de) Tintenrezepturen und verwendung derselben
ATE522506T1 (de) 4-aminopicolinate und ihre verwendung als herbizide
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
DE60207627D1 (de) Überzug und Überzugszusammensetzung
DE60230131D1 (de) Malonitril-verbindungen und ihre verwendung als pestizide
DE60209486D1 (de) Pyranoindazole und ihre verwendung in der glaukombehandlung
ATE456657T1 (de) Aromatische methyltransferasen und ihre verwendung
DE60112635D1 (de) Ölzusammensetzung und ihre Verwendung
DE50206094D1 (de) Substituierte isoindole und ihre verwendung
ATE419366T1 (de) Tyra-gene und ihre verwendung
DE60230162D1 (de) Polymerisate und ihre verwendung
ATE419248T1 (de) Phenylsubstituierte 4-hydroxy-tetrahydropyridone und ihre verwendung als schädlingsbekämpungsmittel und herbizide
DE50106596D1 (de) Haftklebemasse und ihre verwendung
DE50202730D1 (de) Substituierte isoindole und ihre verwendung
ATE316087T1 (de) Isothiazol-derivate und ihre verwendung als schädlingsbekämpfungsmittel
ATE431144T1 (de) Neue formulierungen und ihre verwendung
DE60222252D1 (de) Acrylester und ihre verwendung
DE60101245D1 (de) Beschichtungszusammensetzung und ihre Verwendung
DE50109516D1 (de) Hetarylsubstituierte homotetram- und homotetronsäuren und ihre verwendung als pestizide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties